Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Anxiety Disorders 5 Breast Neoplasms 4 Pain 3 Fatigue 2 Depression 2 Vulvar Neoplasms 1 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stress, Psychological 1 Rectal Neoplasms 1 Personal Satisfaction 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Myasthenia Gravis 1 Malignant Solid Neoplasm 1 Inflammation 1 Hematopoietic and Lymphatic System Neoplasm 1 Femininity 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cancer Pain 1 A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania 1

Interventions

rozanolixizumab 11 efgartigimod alfa 10 zilucoplan 8 Prednisone 8 Cyclophosphamide 8 ravulizumab 7 Rituximab 7 Pyridostigmine Bromide 7 telitacicept 6 fludarabine 6 Tacrolimus 6 Mycophenolic Acid 6 eculizumab 5 Immunoglobulins, Intravenous 5 Hizentra 4 Azathioprine 4 Steroids 3 HBM9161 3 Data Collection 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Exercise 2 Diagnostic Self Evaluation 2 Blood Specimen Collection 2 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Art Therapy × Clear all

NCT07125105 2025-08-15

APART-MG

Universite du Littoral Cote d'Opale

Phase NA Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡